Zoetis (ZTS) Assets Average (2013 - 2026)
Zoetis (ZTS) reported Assets Average of $15.3 billion for Q1 2026, up 8.15% year-over-year from $14.2 billion in Q1 2025, and little changed quarter-over-quarter from $15.3 billion in Q4 2025.
Zoetis (ZTS) Assets Average (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has 14 years of Assets Average data on file, last reported at $15.3 billion in Q1 2026.
- Assets Average for Q1 2026 came in at $15.3 billion, up 8.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.3 billion (up 8.15% YoY), and the FY2025 annual result was $14.9 billion, up 4.22% from the prior year.
- Assets Average steadied at $15.3 billion in Q1 2026 per ZTS's latest filing, from $15.3 billion in the prior quarter.
- Over five years, Assets Average peaked at $15.3 billion in Q4 2025 and troughed at $13.7 billion in Q3 2022.
- A 5-year average of $14.3 billion and a median of $14.3 billion in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2026: Assets Average slipped 1.19% in 2022, then grew 8.15% in 2026.
- A 5-year view of Assets Average shows it stood at $14.3 billion in 2022, then fell by 0.72% to $14.2 billion in 2023, then gained by 0.71% to $14.3 billion in 2024, then rose by 7.19% to $15.3 billion in 2025, then retreated by 0.02% to $15.3 billion in 2026.
- Business Quant data shows ZTS's Assets Average at $15.3 billion in Q1 2026, $15.3 billion in Q4 2025, and $14.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 364.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.32 Bn |
| Dec 31, 2025 | 15.32 Bn |
| Sep 30, 2025 | 14.82 Bn |
| Jun 30, 2025 | 14.29 Bn |
| Mar 31, 2025 | 14.17 Bn |
| Dec 31, 2024 | 14.30 Bn |
| Sep 30, 2024 | 14.26 Bn |
| Jun 30, 2024 | 14.26 Bn |
| Mar 31, 2024 | 14.32 Bn |
| Dec 31, 2023 | 14.20 Bn |
| Sep 30, 2023 | 13.93 Bn |
| Jun 30, 2023 | 13.75 Bn |
| Mar 31, 2023 | 14.34 Bn |
| Dec 31, 2022 | 14.30 Bn |
| Sep 30, 2022 | 13.72 Bn |
| Jun 30, 2022 | 13.82 Bn |
| Mar 31, 2022 | 13.88 Bn |
| Dec 31, 2021 | 13.80 Bn |
| Sep 30, 2021 | 13.89 Bn |
| Jun 30, 2021 | 13.93 Bn |